AH APOLLO MERGER SUB II LLC – Trademark Portfolio
Entity Type: 03
AH APOLLO MERGER SUB II LLC holds 6 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 4 filings in this category. The portfolio also extends into Class 44 (Medical Services) across 2 Nice Classification classes. Currently, 6 trademarks are registered. Notable registered marks include ARX, BUYPAP, AEROCARE, BUYPAPUSA, and SLEEP A LITTLE EASIER. The owner is based in PLYMOUTH MEETING, PA.
220 W. GERMANTOWN PIKE
SUITE 250
PLYMOUTH MEETING, PA 19462
Showing of trademarks Trademarks
Trademark Classifications
AH APOLLO MERGER SUB II LLC's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Advertising; business management; business administration; office functions
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademarks does AH APOLLO MERGER SUB II LLC have?
AH APOLLO MERGER SUB II LLC has 6 U.S. trademarks filed with the USPTO. Of these, 6 registered.
What trademark classes does AH APOLLO MERGER SUB II LLC file in?
AH APOLLO MERGER SUB II LLC files trademarks across 2 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 44 (Medical Services). Class 35 covers advertising; business management; business administration; office functions.
What are AH APOLLO MERGER SUB II LLC's most well-known trademarks?
AH APOLLO MERGER SUB II LLC's registered trademark portfolio includes well-known marks such as ARX, BUYPAP, AEROCARE, BUYPAPUSA, and SLEEP A LITTLE EASIER. These are among 6 currently registered trademarks in the portfolio.
What is AH APOLLO MERGER SUB II LLC's trademark registration success rate?
AH APOLLO MERGER SUB II LLC has a 100% trademark registration rate, with 6 out of 6 resolved applications resulting in successful registration. Currently, 0 applications are pending review.